S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2021-09	Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16) Han, Hye Sook; Kim, Bum Jun; Jee, Hee-Jung; Ryu, Min-Hee; Park, Se Hoon; Rha, Sun Young; Kim, Jong Gwang; Bae, Woo Kyun; Lee, Keun-Wook; Oh, Do-Youn; Kim, In-Ho; Sym, Sun Jin; Oh, So Yeon; Kim, Hyeong Su; Byun, Ji-Hye; Kim, Dong Sook; Suh, Young Ju; An, Hyonggin; Zang, Dae Young Therapeutic Advances in Medical Oncology, Vol.13	DOI
2022-05	Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16) Kim, Bum Jun; Jee, Hee-Jung; Rha, Sun Young; Han, Hye Sook; Ryu, Min-Hee; Park, Se Hoon; Kim, Jong Gwang; Bae, Woo Kyun; Lee, Keun-Wook; Oh, Do-Youn; Byun, Ji-Hye; Kim, Dong Sook; Suh, Young Ju; An, Hyonggin; Zang, Dae Young Gastric Cancer, Vol.25 No.3, pp.609-618	DOI